Oropharynx Cancer Clinical Trials in Baltimore, Maryland
2 recruitingBaltimore, Maryland
Showing 1–2 of 2 trials
Recruiting
Phase 2
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
Head and Neck CancerHead and Neck Squamous Cell CarcinomaHPV Positive Oropharyngeal Squamous Cell Carcinoma+2 more
University of Maryland, Baltimore61 enrolled5 locationsNCT06088381
Recruiting
Special Care Patterns for Elderly HNSCC Patients Undergoing Radiotherapy
HNSCCOral Cavity CancerOropharynx Cancer+2 more
University Hospital Freiburg1,500 enrolled18 locationsNCT05337631